Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalat in essential hypertension (extension study)
NCT01355367Phase 3Completed
- Sponsor
- Bayer
- Start
- Jan 2011
- Primary completion
- Sep 2011
- Countries
- 1
01
Overview
A Phase 3 trial of nifedipine in essential hypertension, sponsored by Bayer. Started Jan 2011; status: completed.
02
Drugs
nifedipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT01355367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01355367.